NASA Launches RapidScat Wind Watcher to Space Station

A new NASA mission that will boost global monitoring of ocean winds for improved weather forecasting and climate studies is among about 5,000 pounds (2,270 kilograms) of NASA science investigations and cargo now on their way to the International Space Station aboard SpaceX's Dragon spacecraft. The cargo ship launched on the company's Falcon 9 rocket from Space Launch Complex-40 at Cape Canaveral Air Force Station in Florida at 10:52 p.m. PDT Saturday, Sept. 20 (1:52 a.m. EDT Sunday, Sept. 21).

The SpaceX mission is the company's fourth cargo delivery flight to the space station through a $1.6 billion NASA Commercial Resupply Services contract. Dragon's cargo will support experiments to be conducted by the crews of space station Expeditions 41 and 42.

The International Space Station-Rapid Scatterometer, or ISS-RapidScat, mission will monitor ocean winds from the vantage point of the space station. This space-based scatterometer, developed by NASA's Jet Propulsion Laboratory, Pasadena, California, is a remote sensing instrument that uses radar pulses reflected from the ocean's surface from different angles to calculate surface wind speed and direction. This information will be useful for weather and marine forecasting and hurricane monitoring.

ISS-RapidScat's berth on the space station will put it in an orbit that is unique from any other wind measuring instrument currently in orbit. This vantage point will give scientists the first near-global direct observations of how ocean winds vary over the course of the day due to solar heating. The new mission will also provide cross-calibration of the international constellation of ocean wind satellites, extending the continuity and usefulness of the scatterometer data record.

Approximately nine days after berthing with the station, the RapidScat instrument and its nadir adapter, which orients the instrument to point down at Earth, will be robotically installed on the External Payload Facility SDX site of the Columbus module over a three-day period by the station's robotic arm, which is controlled by ground controllers at NASA's Johnson Space Center. ISS- RapidScat is an autonomous payload, requiring no interaction from station astronauts.

Using a different end effector -- a mechanical hand -- the station's robotic arm will first extract RapidScat's nadir adapter from the trunk of the Dragon and install it on an external site on the Columbus module. The arm will then pluck the RapidScat instrument assembly from the Dragon's trunk and attach it to the nadir adapter, completing the installation. Each of the two operations will take about six hours.

Once installed, RapidScat will be activated over a period of three days. Checkout of RapidScat will be completed approximately two weeks after installation. About two weeks of preliminary calibration and validation will then follow. RapidScat will then be ready to begin its two-year science mission.

Dragon also will deliver the first-ever 3-D printer in space. The technology enables parts to be manufactured quickly and cheaply in space, instead of waiting for the next cargo resupply vehicle delivery. The research team also will gain valuable insight into improving 3-D printing technology on Earth by demonstrating it in microgravity.

New biomedical hardware launched aboard the spacecraft will help facilitate prolonged biological studies in microgravity. The Rodent Research Hardware and Operations Validation (Rodent Research-1) investigation provides a platform for long-duration rodent experiments in space. These investigations examine how microgravity affects animals, providing information relevant to human spaceflight, discoveries in basic biology and knowledge that may have direct impact toward human health on Earth.

Read this article:

NASA Launches RapidScat Wind Watcher to Space Station

Nanotech can help tackle terrorism: Researchers

New Delhi, Sep 21: Self-reliance in nanotechnology can help India become self-reliant in sectors like defence and in combating terrorism, according to researchers at the Indian Institute of Science in Bangalore.

From water purification to manufacturing to wrinkle-free fabrics to curing cancer, nano technology holds great potential for India and a multi-pronged approach will ensure that this is fully leveraged, they said.

One possible means of bridging the gap between India's abundant, varied natural resources and her ever-increasing requirements like clean water, food and rapid, low-cost diagnostic machinery is the use of nanotechnology, say Arindam Ghosh and Yamuna Krishnan in the international journal Nature Nanotechnology.

Nanotechnology is manipulation of matter on a scale of nanometre or 0.000000001 m. Since the dimensions of atoms and molecule are in nanometres, this technology is called nanotechnology and the resulting materials nanomaterials.

Although India promoted research in nanotechnology through the "NanoScience and Technology Initiative", started with a funding of Rs 60 crore, the country launched a five-year programme 'Nano Mission' with wider objectives and larger funding of USD 250 million spanning multiple areas like basic research in nanotechnology, human resources development, infrastructure development and international collaboration, there is lot of room for improvement, the researchers quoted by Gubbi Labs say.

But, the research says that the amount India spends on nanotechnology research is still just a fraction of the research spending of countries like Japan, the US, France and China.

PTI

Story first published: Sunday, September 21, 2014, 11:00 [IST]

Original post:

Nanotech can help tackle terrorism: Researchers

Mass. governor returns from European trade mission

Updated: 09/20/2014 11:32 PM Created: 09/20/2014 10:48 PM WNYT.com By: Steve Flamisch

GREAT BARRINGTON Gov. Deval Patrick met with supporters in Western Massachusetts on Saturday, hours after flying back from a week-long trade mission to Western Europe.

"We just got off the plane a few hours ago, and hustled right out to God's country here in the Berkshires," Patrick said in a one-on-one interview with NewsChannel 13.

During his overseas trip, the governor toured a wind form off the coast of Denmark, courting investors for a similar project in Massachusetts.

He then traveled to the United Kingdom, meeting with British government officials and leaders in the fast-growing life sciences industry.

And the governor wrapped-up in France, announcing that a Paris-based nano-medicine company will open its first U.S. office in the Bay State.

"It's all about jobs," Patrick said. "You know, this is a global economy. If you want to be in the global economy, and not just talk about it, you've got to get out there."

But critics have said Patrick, a Democrat, is padding his resume for a presidential run or a new job. After visiting one country in his first term, he has traveled to 15 countries in his second and final term.

"He says hes taking these trips to help the economy of Massachusetts, but personally, I think hes doing it for Deval Patrick," Republican state committee member Mike Case told NewsChannel 13.

"Hes not running for re-election, so hes got to find something to do after he leaves office," said Case, whose area includes Berkshire County.

Excerpt from:

Mass. governor returns from European trade mission

Mobile app for clicking selfie with ISRO's Mangalyaan

City-based start-up Smartur has developed a mobile application (app) built on augmented reality that allows users of Android phone users and iOS mobile devices to click a selfie with Indian spaceship Mangalyaan that is due to land on Mars next week.

The Smartur app will provide the mobile users a platform to experience and participate in India's most important space programme milestone - the historic arrival of Mangalyaan on Mars on September 24, according to a release here on Sunday.

The Smartur app is an augmented reality app that has been developed using a 3D model and provides the user with an almost 'real' experience of seeing the object (in this case Mangalyaan) in their living environment, the release said.

The app allows the participants to click and upload/ share innovative pictures that can look like Mangalyaan is lifting off from their hands or out of their car or any other idea that comes to their mind, it said.

A participant would be required to download the app for free on their mobile device and take a print out of the 'Marker' (a marker is a design that helps the model the Mangalyaan to be placed in reality). The combination of the app and marker would give users an actual feel of being right there with the Mangalyaan, it said.

Originally posted here:

Mobile app for clicking selfie with ISRO's Mangalyaan

Half Life 2: Episode One – Taste of Your Own Medicine – Episode 5 – Video


Half Life 2: Episode One - Taste of Your Own Medicine - Episode 5
Episode 5 in my Half Life 2: Episode One let #39;s play. Thanks a lot for watching and please remember to Like, Favourite and Subscribe for more! Facebook: - https://www.facebook.com/Hwx11 Previous...

By: Hwx11

Originally posted here:

Half Life 2: Episode One - Taste of Your Own Medicine - Episode 5 - Video

Michael Christian – Quantum University Graduate – Doctorate and PhD in Integrative Medicine – Video


Michael Christian - Quantum University Graduate - Doctorate and PhD in Integrative Medicine
Learn more about Quantum University at http://www.iquim.org ""It #39;s not at all strange tradition but my daughter said, ""Speak English, dad."" It #39;s funny because in Australia I actually work with...

By: Quantum University

More:

Michael Christian - Quantum University Graduate - Doctorate and PhD in Integrative Medicine - Video

PATHE Study Medicine sees steady growth

Celebrating academic excellence and successful operations of the PATHE Study Medicine 2014 VSMU Alumni get-together was held amidst much festive flair on September 19 at Taj Samudra hotel. The events was Graced by Professor Vadzmin V Prystupa, Head of International Department of the Vitebsk Medical University (VSMU), this year's event provided an ideal networking platform for the past students who shared their experiences. The event saw the participation of newly pass out graduates, parents, senior consultants, students, well-wishers and many more distinguished invitees.

The PATHE Study Medicine, a fully owned division of ANC Education, in collaboration with VSMU has paved the way for many skilled Sri Lankan students to study medicine in Belarus and become a medical doctor. Over the years PATHE Study Medicine has seen a steady growth in is demand due to the quality of academic standards and reliable and transparent transfer processes that are maintained by both PATHE Study Medicine and VSMU. This year PATHE Study Medicine has achieved a significant milestone of enrolling 80 students to VSMU in Belarus providing the opportunity for Sri Lankan students to enter a globally recognized European medicinal degree at an affordable cost of Just 3.2 million for a 6-year duration.

Assistant General Manager, Enrollment Management ANC Education, Gishan Sumanasiri said, We have been able to maintain extremely successful operations since the inception of the PATHE Study Medicine. The university has highly commended to standards of Sri Lankan students.

This is very important in the context where a bilateral relations between the two countries have also been strengthened. We want to encourage more Sri Lankan students to make use of this opportunity as there are few more seats available for VSMU in next few months. We have a very strong bond with PATHE study Medicine and ANC Education and we envision this partnership to grow since it provides a valuable opportunity for hard working Sri Lankan students to study in a Belarusian State university. Nearly all Sri Lankan students have displayed very good academic performance proving their skills, said Professor Vadzmin V. Prystupa. More information could be obtained from http://www.pathestudy.org or Facebook page. http://www.facebook.com/PatheStudy

Link:

PATHE Study Medicine sees steady growth

Hospitals pair Western, Chinese medicine in trial

Vicki Cheng

Monday, September 22, 2014

Three public hospitals will begin offering integrated Chinese-Western medicine services today.

The Hospital Authority's Integrated Chinese- Western Medicine Pilot Project will be a testing platform for doctors of both types of medicine to cooperate in setting out a clinical framework for hospital care.

Western medicine will be the main form of treatment and Chinese medicine will play an assisting role. Chinese and Western medicine doctors are encouraged to pair up when going into the sickroom to observe the in-patients together.

The two doctors will write in the same diary exchanging information before designing a treatment plan.

Cheung Wai-lun, director (cluster services) of the Hospital Authority, said: "This is not a research program on the medical value of Chinese-Western combined medicine. It is to try out the system to run this kind of protocol across the entire public medical network in future."

The first phase of the project, which will last for six months, will be carried out among stroke patients at Tung Wah Hospital in Sheung Wan, palliative care at Tuen Mun Hospital and acute low back pain at Pamela Youde Nethersole Eastern Hospital in Chai Wan. This will be followed by an evaluation before the next phase begins in March.

Three Chinese medicine centers for training and research will send out practitioners with at least four years' experience to join the project under a senior supervisor.

The authority's chief of Chinese medicine and integrative medicine, Eric Ziea Tat-chi, said he hopes the program can provide training opportunities for Chinese medicine doctors as well.

Continued here:

Hospitals pair Western, Chinese medicine in trial

'Precision medicine' offers hope for liposarcoma tumours

As Toronto Mayor Rob Ford begins chemotherapy for the liposarcoma tumour in his abdomen, doctors may need to try several drugs before they find one that works. But there's hope of better treatments to come in the future through a new technology called "precision medicine."

Cancers are notoriously varied, so even two patients with the very same kind of cancer will respond differently to the same chemotherapy medications. That's because as tumours grow, the genes in the cancer cells mutate in different ways. For every type of cancer, there are different mutations.

Quickly finding the right drugs that will work on these growing tumours is critical, since the side effects of chemotherapy can be devastating.

Now, doctors have found a new way to learn more about the genetics on a patient's tumour, to guide them in their search for the right drug.

A research firm in the U.S. called Champions Oncology developed something it calls Tumorgraft. It takes a small sample of the patient's tumour, and implant them into specialized mice that have been bred without immune systems. The lab then tests different drugs to see which works best on the mice. Since the mice have no immune systems of their own, the researchers can be sure it's the drugs that cause tumours to shrink in some of the mice.

Toronto resident Yaron Panov has undergone precision medicine for the same kind of cancer Ford has: pleomorphic liposarcoma. When Panov was diagnosed in 2010, doctors tried surgery, but the treatment failed and after just three months, the tumour grew back and spread.

Doctors suggested chemotherapy but were not optimistic for Panov's chances.

"I was given just a few months to live," he told CTV News.

Panov's wife, Dr. Rochelle Schwartz, herself a physician, had heard about precision medicine treatments being developed at Champions Oncology and the couple flew to the States.

There, testing on lab mice implanted with Panov's tumour cells revealed that the usual chemotherapy drug that would have been given to Panov would not have worked on him. But a drug developed for colon cancer, on the other hand, showed excellent effectiveness.

Read the original post:

'Precision medicine' offers hope for liposarcoma tumours

Harnessing Genetics to Identify Druggable Targets and Causes of Off-Target Cardiotoxicity – Video


Harnessing Genetics to Identify Druggable Targets and Causes of Off-Target Cardiotoxicity
Christopher Newton-Cheh, MD, MPH Assistant Professor of Medicine Harvard Medical School Director, Electrocardiography Laboratory Faculty, Cardiovascular Research Center Center for Human Genetic...

By: Duke Clinical Research Institute

Original post:

Harnessing Genetics to Identify Druggable Targets and Causes of Off-Target Cardiotoxicity - Video